Pulmonary Arterial Hemodynamic Monitoring for Chronic Obstructive Pulmonary Disease Assessment and Treatment

• US 20130245469A1
• Filed: 03/15/2013
• Published: 09/19/2013
• Est. Priority Date: 03/19/2012
• Status: Abandoned Application

• Current Assignee: CardioMEMS Incorporated
• Original Assignee: CardioMEMS Incorporated
• Inventors: White, Jason, Yadav, Jay, Jordan, Ralph
• Application Number:
  US13/843,553
• Publication Number:
  US 20130245469A1
• Time in Patent Office: Days
• US Class Current: 600/505
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/0215 by means inserted into the body catheters A61M25/00

Abstract

Provided herein are methods for assessing, treating, and for developing new treatments for COPD. Methods can involve obtaining one or more PA hemodynamic readings from a subject with COPD, processing the PA hemodynamic readings to obtain one or more PA hemodynamic parameters, and using the one or more PA hemodynamic parameters to assess, treat, and/or develop new treatments for COPD. The methods can optionally be used to evaluate the progress of (COPD) in a subject, or to predict an outcome in a subject having COPD.

Claims

1. A method of predicting the progression or improvement of chronic obstructive pulmonary disease (COPD) in a subject, or predicting an outcome in a subject having COPD, comprising

a. obtaining a pulmonary arterial (PA) hemodynamic reading from the subject, wherein the PA hemodynamic reading comprises a PA hemodynamic waveform;

b. processing the PA hemodynamic waveform to obtain a PA hemodynamic parameter; and

c. comparing the PA hemodynamic parameter obtained from the subject to a standard;

wherein an increase or decrease in the PA hemodynamic parameter as compared to the standard indicates the progression of COPD, the improvement of COPD, the outcome of COPD, or a combination thereof.

2. The method of claim 1, further comprising administering a treatment to the subject, wherein the treatment is selected based on the progression of COPD, the improvement of COPD, the outcome of COPD, or a combination thereof.

3. The method of claim 1, wherein the PA hemodynamic reading includes an ambulatory PA hemodynamic reading.

4. The method of claim 3, wherein the PA hemodynamic reading is obtained wirelessly from an implanted pressure sensor implanted in a pulmonary artery.

5. The method of claim 4, wherein the sensor lacks percutaneous connections.

6. The method of claim 5, wherein the sensor is energized from an external source to return pressure readings by an electromagnetic field.

7. The method of claim 6, wherein the PA hemodynamic reading is taken while the subject is exercising.

8. The method of claim 7, wherein the PA hemodynamic reading is obtained using an ambulatory unit.

9. The method of claim 8, wherein the PA hemodynamic reading comprises a high-fidelity PA hemodynamic waveform.

10. A method of evaluating the progression of heart failure (HF) in a subject comprising obtaining a pulmonary arterial (PA) hemodynamic reading from the subject using an implantable pressure sensor, and comparing the PA hemodynamic reading to a standard,

wherein the PA hemodynamic reading is taken while the subject is exercising, and

wherein an increase or decrease in the PA hemodynamic reading as compared to the standard indicates the progression of HF, the improvement of HF, the outcome of HF, or a combination thereof.

11. The method of claim 10, wherein the heart failure comprises right heart failure.

12. The method of claim 11, wherein the PA hemodynamic reading comprises a high-fidelity PA hemodynamic waveform.

13. The method of claim 12, wherein the PA hemodynamic reading is obtained from the implantable pressure sensor using an ambulatory unit.

14. An ambulatory unit for measuring a physical parameter detected by a wireless sensor, the system comprising:

an antenna providing electromagnetic coupling to the wireless sensor, wherein a signal the physical parameter is received through the antenna;

a processing unit and a memory operably coupled to the processing unit, the memory having computer executable instructions stored thereon that, when executed by the processing unit, cause the processing unit to;

cycle between a communication mode and a low power mode; and

communicate the signal to a remote base unit over a communication link during the communication mode.

15. The ambulatory unit of claim 14, wherein the processing unit is prohibited from communicating the signal to the remote base unit during the low power mode.

16. The ambulatory unit of claim 15, wherein the cycle is determined by the remote base unit.

17. The ambulatory unit of claims 16, further comprising a transceiver for communicating with the remote base unit, wherein the transceiver is configured to initiate the communication mode, wherein the communication mode comprises a transmission window and a non-transmission window.

18. The ambulatory unit of claim 17, wherein a length of the transmission window is related to a characteristic of the signal.

19. The ambulatory unit of claim 18, wherein the characteristic is a signal-to-noise ratio.

20. The ambulatory unit of claim 19, the memory having further computer-executable instructions stored thereon that, when executed by the processing unit, cause the processing unit to decrease the length of the transmission window when the signal-to-noise ratio is below a predetermined threshold.

21. The ambulatory unit of claims 20, wherein the communication link is a wireless communication link.

22. The ambulatory unit of claims 21, the memory having further computer-executable instructions stored thereon that, when executed by the processing unit, cause the processing unit to obtain information related to the signal.

23. The ambulatory unit of claims 22, wherein the wireless sensor comprises an implanted pressure sensor implanted in the pulmonary artery of a patient, and wherein the physical parameter comprises a PA hemodynamic reading.